Horizon Kinetics - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 726 filers reported holding GLAXOSMITHKLINE PLC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
Horizon Kinetics ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q4 2018$933,000
-4.9%
24,4230.0%0.03%
+25.0%
Q3 2018$981,000
-0.4%
24,4230.0%0.02%
-4.0%
Q2 2018$985,000
+3.2%
24,4230.0%0.02%
-10.7%
Q1 2018$954,000
+11.3%
24,423
+1.0%
0.03%
+12.0%
Q4 2017$857,000
-18.8%
24,173
-6.9%
0.02%
-19.4%
Q3 2017$1,055,000
+1.6%
25,975
+7.9%
0.03%
-8.8%
Q2 2017$1,038,000
+2.3%
24,0730.0%0.03%
+6.2%
Q1 2017$1,015,000
+10.0%
24,073
+0.4%
0.03%
+6.7%
Q4 2016$923,000
-17.6%
23,973
-7.7%
0.03%
-3.2%
Q3 2016$1,120,000
-0.4%
25,9730.0%0.03%
+10.7%
Q2 2016$1,125,000
+6.8%
25,9730.0%0.03%
+7.7%
Q1 2016$1,053,000
-1.0%
25,973
-1.4%
0.03%
+13.0%
Q4 2015$1,064,000
+7.6%
26,348
+2.4%
0.02%
+27.8%
Q3 2015$989,000
-0.3%
25,723
+8.0%
0.02%
+28.6%
Q2 2015$992,000
-9.6%
23,823
+0.2%
0.01%
-6.7%
Q1 2015$1,097,000
+8.2%
23,773
+0.2%
0.02%
+7.1%
Q4 2014$1,014,000
-8.2%
23,723
-1.2%
0.01%0.0%
Q3 2014$1,104,000
-14.0%
24,022
+0.1%
0.01%
-12.5%
Q2 2014$1,283,000
+0.9%
23,992
+0.8%
0.02%0.0%
Q1 2014$1,271,000
+0.3%
23,792
+0.3%
0.02%0.0%
Q4 2013$1,267,000
+6.5%
23,7230.0%0.02%0.0%
Q3 2013$1,190,000
+5.0%
23,723
+4.6%
0.02%
-5.9%
Q2 2013$1,133,00022,6730.02%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2015
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders